| Methods |
Randomised, parallel group, double blind study |
| Participants |
245 participants randomised to 3 groups, no withdrawals
Number randomised to intervention 78
Number randomised to placebo 84: male:female, 40% male over both groups
Number of third molars removed: 1 or 2 for each patient
Baseline pain intensity: moderate to severe 65‐76% in both groups
Setting: dental practice (Germany) |
| Interventions |
Paracetamol 1000 mg versus placebo
Formulation: tablets
Anaesthesia: LA |
| Outcomes |
PI: not stated
PR given as TOTPAR at 6 hours
Global assessment: categorical 1‐5 (poor ‐ excellent)
Adverse effects not stated |
| Notes |
Sponsored by
Novartis Consumer Health |
| Risk of bias |
| Bias |
Authors' judgement |
Support for judgement |
| Allocation concealment (selection bias) |
Unclear risk |
B ‐ Unclear |
